Fortune Brands Innovations, Inc. (NYSE:FBIN) Q4 2025 Earnings Call Transcript February 12, 2026 Fortune Brands Innovations, Inc. misses on earnings expectations. Reported EPS is $0.86 EPS, ...

Neurocrine Biosciences, Inc. leverages a strong cash position and a neuropsychiatry pipeline to drive long-term commercial ...

Being a sports reporter has to be mind boggling and very stressful, taking in games basically every night of the week has to take its toll. Swami in his younger years had thought he would like to have ...

2026 outlook -- EBITDA -- Full-year EBITDA guidance is $2.05 billion to $2.15 billion, representing 3%-8% comparable currency-neutral growth; productivity and efficiency gains are expected to fund ...

FY 2025 sales growth of 10.9% at CER1, or 8.1% as reported, driven by growth of the three therapeutic areas of Oncology ...

Management described robust demand across aerospace, naval, and test segments, explicitly crediting the ESCO Maritime ...

Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong ...

Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote for ...

Mark Sheahan, President and CEO, highlighted record sales for both the fourth quarter and full year, stating, "Sales were up 8% in the fourth quarter with acquisitions contributing 4% of the growth.

When you are unwell or about to fall sick, whom do you ask for help? Your mom or dad? Maybe your siblings or friends? How long before you get in front of an actual doctor? Increasingly, going to the ...

The expert anglers at Milliken Fishing prove the locals wrong after finding big bass where none were expected. Trump wants nations to pay $1 billion to stay on peace board Leader linked to ISIS ambush ...